文献速递胰腺与胆道疾病

胰腺炎及恢复期的新型循环与组织单核细胞及巨噬细胞

Novel Circulating and Tissue Monocytes as Well as Macrophages in Pancreatitis and Recovery.
PubMed 文献 · Gastroenterology · 2021-08-25

该研究采用单细胞质谱流式技术(CyTOF)分析实验性轻症急性胰腺炎(AP)、重症急性胰腺炎(SAP)及恢复期模型和患者血液,发现Ly6C+炎性单核细胞是胰腺中最显著变化的细胞,并鉴定出AP/恢复期7个新单核细胞亚群、SAP 6个亚群以及CD206+巨噬细胞7个新亚群,其表面和功能标志物与恢复和SAP相关。

要点

  • Ly6C+炎性单核细胞在实验性AP、恢复期和SAP的胰腺中变化最显著。
  • 鉴定出AP和恢复期7个新单核细胞亚群、SAP 6个亚群及CD206+巨噬细胞7个新亚群。
  • CD206+巨噬细胞亚群促炎/抗炎细胞因子表达随疾病进展或缓解而不同。

核心结论

  • 鉴定出若干具有独特表型和功能特征的新型单核/巨噬细胞亚群,与AP、恢复期和SAP相关。
  • 研究结果揭示了AP进展和恢复过程中不同的先天免疫反应,可用于未来疾病监测和靶向治疗。

研究设计与样本

  • 采用单细胞质谱流式技术(CyTOF)分析2个独立实验模型的胰腺和全身炎症信号,以及AP和复发性AP患者血液。
  • 对CyTOF分析鉴定的单核细胞亚群独立进行流式细胞术验证。

主要发现

  • Ly6C+炎性单核细胞是实验性AP、恢复期和SAP胰腺中变化最显著的细胞。
  • 深度分析发现胰腺和血液单核细胞异质性,鉴定出AP和恢复期7个新亚群、SAP 6个亚群。
  • AP和恢复期胰腺CD206+巨噬细胞群体呈动态变化,并鉴定出AP、恢复期和SAP中7个新亚群。
  • 差异表达分析显示这些新亚群表面标志物(CD44、CD54、CD115、CD140a、CD196、podoplanin)和功能标志物(干扰素-γ、白介素4、白介素22、LAP-TGF-β、肿瘤坏死因子-α、T-bet、RoRγt)显著改变,与恢复和SAP相关。
  • 靶向功能分析显示胰腺CD206+巨噬细胞亚群在疾病进展或缓解时促炎和抗炎细胞因子表达不同。

临床怎么用

  • 这些新型单核/巨噬细胞亚群及其标志物可能作为AP进展、恢复和SAP的监测指标。
  • 研究提示可针对特定先天免疫细胞亚群开发未来治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Acute pancreatitis (AP) is an inflammatory disease with mild to severe course that is associated with local and systemic complications and significant mortality. Uncovering inflammatory pathways that lead to progression and recovery will inform ways to monitor and/or develop effective therapies. METHODS: We performed single-cell mass Cytometry by Time Of Flight (CyTOF) analysis to identify pancreatic and systemic inflammatory signals during mild AP (referred to as AP), severe AP (SAP), and recovery using 2 independent experimental models and blood from patients with AP and recurrent AP. Flow cytometric validation of monocytes subsets identified using CyTOF analysis was performed independently. RESULTS: Ly6C+ inflammatory monocytes were the most altered cells in the pancreas during experimental AP, recovery, and SAP. Deep profiling uncovered heterogeneity among pancreatic and blood monocytes and identified 7 novel subsets during AP and recovery, and 6 monocyte subsets during SAP. Notably, a dynamic shift in pancreatic CD206+ macrophage population was observed during AP and recovery. Deeper profiling of the CD206+ macrophage identified 7 novel subsets during AP, recovery, and SAP. Differential expression analysis of these novel monocyte and CD206+ macrophage subsets revealed significantly altered surface (CD44, CD54, CD115, CD140a, CD196, podoplanin) and functional markers (interferon-γ, interleukin 4, interleukin 22, latency associated peptide-transforming growth factor-β, tumor necrosis factor-α, T-bet, RoRγt) that were associated with recovery and SAP. Moreover, a targeted functional analysis further revealed distinct expression of pro- and anti-inflammatory cytokines by pancreatic CD206+ macrophage subsets as the disease either progressed or resolved. Similarly, we identified heterogeneity among circulating classical inflammatory monocytes (CD14+CD16-) and novel subsets in patients with AP and recurrent AP. CONCLUSIONS: We identified several novel monocyte/macrophage subsets with unique phenotype and functional characteristics that are associated with AP, recovery, and SAP. Our findings highlight differential innate immune responses during AP progression and recovery that can be leveraged for future disease monitoring and targeting.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Manohar M, Jones EK, Rubin SJS, et al. Novel Circulating and Tissue Monocytes as Well as Macrophages in Pancreatitis and Recovery. Gastroenterology. 2021. PMID: 34450180. doi:10.1053/j.gastro.2021.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。